Actively Recruiting
Diet Study for Adults with Moderately Active Ulcerative Colitis Comparing Normal Diet to One Without Certain Food Additives
Led by Region Skane · Updated on 2026-01-12
70
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of dietary changes on patients with moderately active ulcerative colitis. This prospective clinical trial compares a normal healthy diet to a diet that eliminates specific emulsifying agents, particularly carrageenan, CMC, and polysorbates, which are part of the E 400 additive group. The goal is to see if removing these additives can improve disease activity and the gut microbiota. Participants are randomly assigned to one of two groups one group receives standard dietary advice for ulcerative colitis, while the other group receives advice to eliminate E400 additives from their diet. Diets are recorded at the beginning and after one month using a food diary and a food frequency questionnaire focused on E400 intake. Clinical characteristics, disease activity markers like diarrhea frequency, blood in stools, abdominal pain, CRP, calprotectin, and microbiota samples are collected and analyzed. During the study, participants will have their diets and clinical status assessed at the start and after one month. Researchers will measure outcomes including calprotectin levels and microbiota diversity to evaluate disease activity and gut health. The study includes monitoring of clinical symptoms and microbiota composition using advanced sequencing methods. Participation involves diet recording and clinical assessments over a one-month period to track changes and safety.
CONDITIONS
Brief Title
Micronutrient and Additive Modifications May Optimize Diet To Health
Research Team
K
Klas Sjöberg, Prof
S
Sanna Davidson, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here